Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Gotham Asset Management LLC

Gotham Asset Management LLC raised its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 126.7% in the fourth quarter, Holdings Channel.com reports. The fund owned 91,166 shares of the pharmacy operator’s stock after acquiring an additional 50,946 shares during the period. Gotham Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $4,755,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. New World Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance in the third quarter worth approximately $392,000. American Century Companies Inc. increased its stake in shares of Walgreens Boots Alliance by 9.2% in the third quarter. American Century Companies Inc. now owns 599,533 shares of the pharmacy operator’s stock valued at $28,208,000 after buying an additional 50,568 shares in the last quarter. First Republic Investment Management Inc. increased its stake in shares of Walgreens Boots Alliance by 14.2% in the third quarter. First Republic Investment Management Inc. now owns 112,658 shares of the pharmacy operator’s stock valued at $5,301,000 after buying an additional 13,988 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich increased its position in Walgreens Boots Alliance by 27.3% in the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,282 shares of the pharmacy operator’s stock worth $60,000 after purchasing an additional 275 shares during the period. Finally, Prospera Financial Services Inc increased its position in Walgreens Boots Alliance by 35.4% in the third quarter. Prospera Financial Services Inc now owns 6,028 shares of the pharmacy operator’s stock worth $284,000 after purchasing an additional 1,576 shares during the period. 57.02% of the stock is owned by institutional investors.

Walgreens Boots Alliance stock opened at $42.08 on Wednesday. Walgreens Boots Alliance, Inc. has a 52 week low of $39.72 and a 52 week high of $55.82. The business has a 50-day simple moving average of $44.70 and a 200 day simple moving average of $47.65. The company has a quick ratio of 0.35, a current ratio of 0.74 and a debt-to-equity ratio of 0.36. The stock has a market cap of $36.35 billion, a price-to-earnings ratio of 5.80, a PEG ratio of 2.21 and a beta of 0.55.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last posted its earnings results on Thursday, March 31st. The pharmacy operator reported $1.59 EPS for the quarter, topping the consensus estimate of $1.39 by $0.20. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 4.62%. The business had revenue of $33.76 billion during the quarter, compared to analysts’ expectations of $33.33 billion. During the same period in the previous year, the business earned $1.40 earnings per share. The firm’s revenue was up 3.0% on a year-over-year basis. On average, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.05 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, June 10th. Shareholders of record on Friday, May 20th will be paid a dividend of $0.4775 per share. This represents a $1.91 annualized dividend and a yield of 4.54%. The ex-dividend date is Thursday, May 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 26.34%.

In other Walgreens Boots Alliance news, major shareholder Walgreens Boots Alliance, Inc. sold 6,000,000 shares of Walgreens Boots Alliance stock in a transaction dated Wednesday, May 11th. The stock was sold at an average price of $150.00, for a total transaction of $900,000,000.00. Following the completion of the sale, the insider now owns 52,854,867 shares of the company’s stock, valued at $7,928,230,050. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 17.40% of the company’s stock.

Several equities research analysts have commented on the company. Cowen cut their target price on Walgreens Boots Alliance from $55.00 to $50.00 in a research note on Tuesday, April 12th. TheStreet downgraded Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research report on Monday, May 2nd. Barclays dropped their target price on Walgreens Boots Alliance from $54.00 to $50.00 and set an “equal weight” rating for the company in a research report on Friday, April 1st. Robert W. Baird cut Walgreens Boots Alliance from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $70.00 to $51.00 in a research note on Friday, April 1st. Finally, UBS Group decreased their target price on Walgreens Boots Alliance from $52.00 to $49.00 and set a “neutral” rating for the company in a research note on Tuesday, April 5th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus target price of $50.71.

Walgreens Boots Alliance Profile (Get Rating)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.